PLC's Heart Laser Takes Over Center Stage
Venture capitalists and big device companies have lamented for years that laser medicine was the black hole of medical device investment. Though the consumer-oriented laser devices have met with modest commercial success, most laser systems have been only marginally effective in the clinic, falling far short of the expected payoff given the investment.
You may also be interested in...
Thermo Fisher Scientific has agreed to buy Mesa Biotech for $450m in cash and Hillrom will acquire Bardy Diagnostics for $375m in cash. Both deals will add complementary digital health solutions, which may be a continued trend in 2021.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Medicare now covers transcatheter edge-to-edge repair for both functional and degenerative mitral regurgitation under specific conditions.